CompletedNCT06189027

Epigenetics and MDMA-Assisted Psychotherapy for PTSD

Medication studyAges 18+United States

The study in practice

Understand this study

This study was for people with PTSD. Listed age limits: from 18 years. Other eligibility criteria applied.

Listed locations: Los Angeles, United StatesSee all locations and recruitment
Activities: Medication described in the protocol · Placebo comparator
Compensation: Payment and expense reimbursement have not been verified.

Study clarity

Study start dateStarted: November 20, 2018

Recruitment status: Completed
Enrollment listed in the registry: 45
Sponsor: University of Southern California
Sponsor type: University
Study type: Behavioral
Intervention type: Psychotherapy / behavioral intervention, Medication / drug
Study phase: Phase 3
Locations: United States
Age range: Over 18 Years
Official registry ID: NCT06189027
Official title: Show the full official title
Epigenetic Regulation of Stress-related Genes in Relation to MDMA-Assisted Psychotherapy Treatment for Post-Traumatic Stress Disorder

Completed

Los Angeles

FAQ

Who is behind this study?

The study sponsor is University of Southern California, a university.

Did this study involve medication?

Yes. The study involved medication, including MDMA.

Who was this study for?

This study was for people with PTSD. Listed age limits: from 18 years. Other eligibility criteria applied.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.